New vaccine aims to stop melanoma from coming back
NCT ID NCT01898039
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 24 times
Summary
This study tests a vaccine made from modified melanoma cells to help the immune system recognize and attack any remaining cancer in patients at high risk of recurrence. It is for people who have had melanoma removed and are now cancer-free or have very little disease left. The goal is to see if the vaccine is safe and can boost the body's natural defenses against the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sharett Institute of Oncology, Hadassah Medical Organization
RECRUITINGJerusalem, 91120, Israel
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.